PAPER Zhang S, Liu H, Ouyang Z, Xu T, Yang Q, Zhu Y, Wan M, Xiao X, Yang X, Chen S, Yuan L, Bei Y, Wang J, Guo J, Chen H, Tang B, Luo S, Jiao B, Shen L
SEARCH RESULTS
348036 RESULTS
PAPER Fatima G, Ashiquzzaman A, Kim SS, Kim YR, Kwon HS, Chung E
Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches.
Neurobiol Dis. 2025 Mar 17;:106877. Epub 2025 Mar 17 PubMed.PAPER Milton S, Cavaillès C, Ancoli-Israel S, Stone KL, Yaffe K, Leng Y
Five-Year Changes in 24-Hour Sleep-Wake Activity and Dementia Risk in Oldest Old Women.
Neurology. 2025 Apr 22;104(8):e213403. Epub 2025 Mar 19 PubMed.PAPER Vaianella L, Bove R, Giuliani A, Pavino V, Guglielmi V, Giacomini G, Rossi C, Massimetti MC, Iani C, Bizzarro A
Assessing brain vascular impairment, white matter lesions and ApoE status as predictors of behavioral and psychological symptoms of dementia (BPSD) in a multicentre sample of patients with Alzheimer's disease: a multidisciplinary retrospective study.
Ann Ist Super Sanita. 2025;61(1):42-49. PubMed.PAPER Ricchi M, Campani G, Nagmutdinova A, Bortolotti V, Greco D, Golini C, Grist J, Brizi L, Testa C
Connectivity related to major brain functions in Alzheimer disease progression: microstructural properties of the cingulum bundle and its subdivision using diffusion-weighted MRI.
Eur Radiol Exp. 2025 Mar 19;9(1):32. PubMed.PAPER Chen YH, Wang ZB, Liu XP, Mao ZQ, Alzheimer's Disease Neuroimaging Initiative
Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer's disease pathology and cognitive decline.
J Alzheimers Dis. 2025 Mar 19;:13872877251326286. Epub 2025 Mar 19 PubMed.PAPER Fah H, Bohn L, Greiner R, Dixon RA
Comparing machine learning classifier models in discriminating cognitively unimpaired older adults from three clinical cohorts in the Alzheimer's disease spectrum: demonstration analyses in the COMPASS-ND study.
Front Aging Neurosci. 2025;17:1542514. Epub 2025 Mar 4 PubMed.PAPER Ur Rahman J, Hanif M, Ur Rehman O, Haider U, Mian Qaisar S, Pławiak P
Stages prediction of Alzheimer's disease with shallow 2D and 3D CNNs from intelligently selected neuroimaging data.
Sci Rep. 2025 Mar 18;15(1):9238. PubMed.PAPER Hendrix SB, Sano M, Lyketsos C, Rosenberg PB, Porsteinsson AP, Brown BL, Hedges D, Cummings JL
Cohen-mansfield agitation inventory total score as a measure of agitation and aggression in Alzheimer's disease: A factor analysis.
Int Psychogeriatr. 2025 Mar 18;:100056. Epub 2025 Mar 18 PubMed.PAPER Hoost SS, Honig LS, Kang MS, Bahl A, Lee AJ, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Dage JL, Brickman AM, Manly JJ, Mayeux R, Gu Y
Association of dietary fatty acids with longitudinal change in plasma-based biomarkers of Alzheimer's disease.
J Prev Alzheimers Dis. 2025 Mar 18;:100117. Epub 2025 Mar 18 PubMed.PAPER Raj A, Torok J, Ranasinghe K
Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer's Disease.
Prog Neurobiol. 2025 Mar 17;:102750. Epub 2025 Mar 17 PubMed.PAPER Kułaga D, Drabczyk AK, Zaręba P, Jaśkowska J, Satała G, Zaręba P, Więckowska A, de Candia M, Purgatorio R, Boguszewska-Czubara A, Sudoł-Tałaj S, Latacz G, Plażuk D
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer's disease symptoms.
Biomed Pharmacother. 2025 Mar 18;186:117995. Epub 2025 Mar 18 PubMed.PAPER Bianchin MM, Zimmer ER
Wake-Up Call: The Association Between Sleep Disturbances and Dementia.
Neurology. 2025 Apr 22;104(8):e213516. Epub 2025 Mar 19 PubMed.PAPER Zhang Z, Han S, Zhu H, Wang Q, Cheng S, Han Y, Li F, Guo J
Global, Regional, and National Burden of Early-Onset Alzheimer's Disease and Other Dementias in Young Adults Aged 40-64 Years, 1990-2021: A Population-Based Study.
Eur J Neurol. 2025 Mar;32(3):e70116. PubMed.PAPER Sullivan AC, Zuniga G, Ramirez P, Fernandez R, Wang CP, Li J, Davila L, Pelton K, Gomez S, Sohn C, Gonzalez E, Lopez-Cruzan M, Gonzalez DA, Parker A, Zilli E, de Erausquin GA, Seshadri S, Espinoza S, Musi N, Frost B
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD).
NPJ Dement. 2025;1(1):2. Epub 2025 Mar 12 PubMed.Current Filters
- Date Range : All x